AntriaBio, Inc., formerly Fits My Style Inc. is a biopharmaceutical company developing novel therapeutic products for the diabetes market. The Company�s product pipeline includes AB101 and AB201 (Long acting GLP-1). AB101 is PEGylated basal insulin that has been formulated in biodegradable microspheres to be injected weekly to treat patients with Type 1 and Type 2 diabetes who require basal insulin to control hyperglycemia. Glucagon-like peptide-1 (GLP) is a naturally occurring peptide in the intestine that helps control glucose levels by stimulating the pancreas to produce insulin, reducing the amount of glucose that is produced by the liver, reducing the rate at which the stomach digests food and empties into the small intestine (gastric emptying) and curbing the appetite and the amount of food that is consumed. As of February 6, 2013, the Company had not generated any revenue.